Evidence Generation for DTx: requirements, challenges & best practices

Finding the right evidence generation strategy for a DTx product can be an arduous task to do, this is why we are organizing this peer-to-peer session where all participants can learn from each other’s knowledge and experiences. Join this session to discuss the following with other senior leaders:

 
- What are the evidence requirements from the different stakeholders and how to address all of them as efficiently as possible? How does this depend on the type of product (PDT vs. nPDT)? 
- The evidence required will change depending on the routes to market you want to take and the claims you need. How to successfully build your evidence generation strategy hand in hand with your commercialization strategy?
- Challenges & Best practices in clinical & economic study design.